Companies

Julia Eschenbrenner and her team want to prevent millions of bone fractures with a new method for the early detection of osteoporosis. She is working towards this ambitious goal with the start-up POROUS at the Potsdam Science Park.

Alexander Gorczyza and his company biocyc develop urgently needed antibodies for cancer diagnostics. At the Potsdam Science Park, he found the space, flexibility and skilled labour to expand.

The innoFSPEC transfer lab is dedicated to transferring knowledge from science to industry. At the lab, researchers and innovation departments of industrial companies meet to jointly test and further develop the application of latest research results, as well as to bring new products and technologies to market maturity. In our interview, research associate Dr. Anne…

Since August 2023, the Roche Group has found a place in the Potsdam Science Park through its subsidiary, Signature Diagnostics GmbH, becoming an important anchor company in the fields of pharmaceuticals and diagnostics. Together with Signature’s Managing Director, Dr Ruediger Ridder, and Agnes von Matuschka, Managing Director of Standortmanagement Golm GmbH in the Science Park,…

For its work in early osteoporosis detection, poroUS GmbH, based in Potsdam Science Park, is receiving funding of €2.5 million through the European Innovation Council Accelerator Grant. In our interview, CEO Julia Eschenbrenner and CTO Jonas Massmann explain how they managed to stand out during the application process and what opportunities the funding will provide…

Enverque covers every step in the diagnostics process for its customers, from sampling to laboratory testing to evaluation. In this way, the company helps bring about improvements in cancer and HIV treatments, for instance. With the Enver app, Enverque is now seeking to provide a “pocket GP” and thus make a major contribution to improving…